| Year |
Citation |
Score |
| 2023 |
Teil M, Dovero S, Bourdenx M, Arotcarena ML, Darricau M, Porras G, Thiolat ML, Trigo-Damas I, Perier C, Estrada C, Garcia-Carrillo N, Herrero MT, Vila M, Obeso JA, Bezard E, et al. Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain. Npj Parkinson's Disease. 9: 135. PMID 37726343 DOI: 10.1038/s41531-023-00579-w |
0.781 |
|
| 2022 |
Teil M, Dovero S, Bourdenx M, Arotcarena ML, Camus S, Porras G, Thiolat ML, Trigo-Damas I, Perier C, Estrada C, Garcia-Carrillo N, Morari M, Meissner WG, Herrero MT, Vila M, et al. Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology. Brain : a Journal of Neurology. PMID 35285474 DOI: 10.1093/brain/awab374 |
0.782 |
|
| 2022 |
Novello S, Mercatelli D, Albanese F, Domenicale C, Brugnoli A, D'Aversa E, Vantaggiato S, Dovero S, Murtaj V, Presotto L, Borgatti M, Shimshek DR, Bezard E, Moresco RM, Belloli S, et al. In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity. Neurobiology of Disease. 162: 105579. PMID 34871735 DOI: 10.1016/j.nbd.2021.105579 |
0.773 |
|
| 2021 |
Arotcarena ML, Dovero S, Biendon N, Dutheil N, Planche V, Bezard E, Dehay B. Pilot Study Assessing the Impact of Intrathecal Administration of Variants AAV-PHP.B and AAV-PHP.eB on Brain Transduction in Adult Rhesus Macaques. Frontiers in Bioengineering and Biotechnology. 9: 762209. PMID 34869273 DOI: 10.3389/fbioe.2021.762209 |
0.482 |
|
| 2021 |
Sun X, Yu X, Zhang L, Zhao W, Wang M, Zhang Y, Li X, Gao R, Breger LS, Dovero S, Porras G, Fernagut PO, Dehay B, Bezard E, Qin C. Comparison of the expression and toxicity of AAV2/9 carrying the human A53T α-synuclein gene in presence or absence of WPRE. Heliyon. 7: e06302. PMID 33665452 DOI: 10.1016/j.heliyon.2021.e06302 |
0.541 |
|
| 2021 |
Yu X, Persillet M, Zhang L, Zhang Y, Xiuping S, Li X, Ran G, Breger LS, Dovero S, Porras G, Dehay B, Bezard E, Qin C. Evaluation of blood flow as a route for propagation in experimental synucleinopathy. Neurobiology of Disease. 105255. PMID 33421564 DOI: 10.1016/j.nbd.2021.105255 |
0.573 |
|
| 2020 |
Bourdenx M, Nioche A, Dovero S, Arotcarena ML, Camus S, Porras G, Thiolat ML, Rougier NP, Prigent A, Aubert P, Bohic S, Sandt C, Laferrière F, Doudnikoff E, Kruse N, et al. Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates. Science Advances. 6: eaaz9165. PMID 32426502 DOI: 10.1126/Sciadv.Aaz9165 |
0.791 |
|
| 2020 |
Arotcarena ML, Dovero S, Prigent A, Bourdenx M, Camus S, Porras G, Thiolat ML, Tasselli M, Aubert P, Kruse N, Mollenhauer B, Damas IT, Estrada C, Garcia-Carrillo N, Vaikath NN, et al. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates. Brain : a Journal of Neurology. PMID 32380543 DOI: 10.1093/Brain/Awaa096 |
0.779 |
|
| 2020 |
Deffains M, Haï Nguyen T, Orignac H, Biendon N, Dovero S, Bezard E, Boraud T. In vivo electrophysiological validation of DREADD-based modulation of pallidal neurons in the non-human primate. The European Journal of Neuroscience. PMID 32306446 DOI: 10.1111/Ejn.14746 |
0.561 |
|
| 2020 |
Faivre F, Sánchez-Catalán MJ, Dovero S, Bido S, Joshi A, Bezard E, Barrot M. Ablation of the tail of the ventral tegmental area compensates symptoms in an experimental model of Parkinson's disease. Neurobiology of Disease. 104818. PMID 32087289 DOI: 10.1016/j.nbd.2020.104818 |
0.592 |
|
| 2019 |
Arotcarena ML, Bourdenx M, Dutheil N, Thiolat ML, Doudnikoff E, Dovero S, Ballabio A, Fernagut PO, Meissner WG, Bezard E, Dehay B. Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies. Jci Insight. 4. PMID 31434803 DOI: 10.1172/Jci.Insight.129719 |
0.783 |
|
| 2019 |
Rosenblad C, Li Q, Pioli EY, Dovero S, Antunes ASLM, Agúndez L, Bardelli M, Linden RM, Henckaerts E, Björklund A, Bezard E, Björklund T. Vector-mediated l-3,4-dihydroxyphenylalanine delivery reverses motor impairments in a primate model of Parkinson's disease. Brain : a Journal of Neurology. PMID 31243443 DOI: 10.1093/Brain/Awz176 |
0.581 |
|
| 2018 |
Novello S, Arcuri L, Dovero S, Dutheil N, Shimshek DR, Bezard E, Morari M. G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice. Neurobiology of Disease. PMID 30172844 DOI: 10.1016/J.Nbd.2018.08.018 |
0.811 |
|
| 2018 |
Chansel-Debordeaux L, Bourdenx M, Dutheil N, Dovero S, Canron MH, Jimenez C, Bezard E, Dehay B. Systemic gene delivery by single-dose intracardiac administration of scAAV2/9 and scAAV2/rh10 variants in newborn rats. Human Gene Therapy Methods. PMID 30064266 DOI: 10.1089/Hgtb.2017.192.R3 |
0.721 |
|
| 2017 |
Chansel-Debordeaux L, Bourdenx M, Dovero S, Grouthier V, Dutheil N, Espana A, Groc L, Jimenez C, Bezard E, Dehay B. In utero delivery of rAAV2/9 induces neuronal expression of the transgene in the brain: towards new models of Parkinson's disease. Gene Therapy. 24: 801-809. PMID 28853717 DOI: 10.1038/Gt.2017.84 |
0.764 |
|
| 2017 |
Soria FN, Engeln M, Martinez-Vicente M, Glangetas C, López-González MJ, Dovero S, Dehay B, Normand E, Vila M, Favereaux A, Georges F, Lo Bianco C, Bezard E, Fernagut PO. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration. Human Molecular Genetics. PMID 28520872 DOI: 10.1093/Hmg/Ddx120 |
0.801 |
|
| 2017 |
Bourdenx M, Dovero S, Thiolat ML, Bezard E, Dehay B. Lack of spontaneous age-related brain pathology in Octodon degus: a reappraisal of the model. Scientific Reports. 7: 45831. PMID 28374864 DOI: 10.1038/Srep45831 |
0.754 |
|
| 2015 |
Bourdenx M, Dovero S, De Deurwaerdère P, Li Q, Bezard E. Early Prenatal Exposure to MPTP Does Not Affect Nigrostrial Neurons in Macaque Monkey. Synapse (New York, N.Y.). PMID 26584009 DOI: 10.1002/Syn.21876 |
0.793 |
|
| 2015 |
Dovero S, Gross C, Bezard E. Unexpected toxicity of very low dose MPTP in mice: A clue to the aetiology of Parkinson's disease? Synapse (New York, N.Y.). PMID 26583879 DOI: 10.1002/syn.21875 |
0.712 |
|
| 2015 |
Bourdenx M, Dovero S, Engeln M, Bido S, Bastide MF, Dutheil N, Vollenweider I, Baud L, Piron C, Grouthier V, Boraud T, Porras G, Li Q, Baekelandt V, Scheller D, et al. Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression. Acta Neuropathologica Communications. 3: 46. PMID 26205255 DOI: 10.1186/S40478-015-0222-2 |
0.802 |
|
| 2014 |
Recasens A, Dehay B, Bové J, Carballo-Carbajal I, Dovero S, Pérez-Villalba A, Fernagut PO, Blesa J, Parent A, Perier C, Fariñas I, Obeso JA, Bezard E, Vila M. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Annals of Neurology. 75: 351-62. PMID 24243558 DOI: 10.1002/Ana.24066 |
0.657 |
|
| 2014 |
Bastide MF, Dovero S, Charron G, Porras G, Gross CE, Fernagut PO, Bézard E. Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia. Neurobiology of Disease. 62: 179-92. PMID 24103779 DOI: 10.1016/J.Nbd.2013.09.020 |
0.615 |
|
| 2012 |
Tass PA, Qin L, Hauptmann C, Dovero S, Bezard E, Boraud T, Meissner WG. Coordinated reset has sustained aftereffects in Parkinsonian monkeys. Annals of Neurology. 72: 816-20. PMID 23280797 DOI: 10.1002/ana.23663 |
0.576 |
|
| 2012 |
Porras G, Berthet A, Dehay B, Li Q, Ladepeche L, Normand E, Dovero S, Martinez A, Doudnikoff E, Martin-Négrier ML, Chuan Q, Bloch B, Choquet D, Boué-Grabot E, Groc L, et al. PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking. The Journal of Clinical Investigation. 122: 3977-89. PMID 23041629 DOI: 10.1172/Jci59426 |
0.586 |
|
| 2012 |
Rotge JY, Aouizerate B, Amestoy V, Lambrecq V, Langbour N, Nguyen TH, Dovero S, Cardoit L, Tignol J, Bioulac B, Burbaud P, Guehl D. The associative and limbic thalamus in the pathophysiology of obsessive-compulsive disorder: an experimental study in the monkey. Translational Psychiatry. 2: e161. PMID 23010765 DOI: 10.1038/Tp.2012.88 |
0.495 |
|
| 2012 |
Dehay B, Dalkara D, Dovero S, Li Q, Bezard E. Systemic scAAV9 variant mediates brain transduction in newborn rhesus macaques. Scientific Reports. 2: 253. PMID 22355765 DOI: 10.1038/Srep00253 |
0.543 |
|
| 2011 |
Tass PA, Qin L, Hauptmann C, Dovero S, Bezard E, Boraud T, Meissner WG. The translational value of the MPTP non-human primate model of Parkinsonism for deep brain stimulation research. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2011: 663-6. PMID 22254396 DOI: 10.1109/IEMBS.2011.6090148 |
0.539 |
|
| 2010 |
Fernagut PO, Li Q, Dovero S, Chan P, Wu T, Ravenscroft P, Hill M, Chen Z, Bezard E. Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeys. Plos One. 5: e14053. PMID 21124922 DOI: 10.1371/Journal.Pone.0014053 |
0.569 |
|
| 2010 |
Rylander D, Parent M, O'Sullivan SS, Dovero S, Lees AJ, Bezard E, Descarries L, Cenci MA. Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Annals of Neurology. 68: 619-28. PMID 20882603 DOI: 10.1002/Ana.22097 |
0.58 |
|
| 2010 |
Santini E, Sgambato-Faure V, Li Q, Savasta M, Dovero S, Fisone G, Bezard E. Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia. Plos One. 5: e12322. PMID 20808799 DOI: 10.1371/Journal.Pone.0012322 |
0.542 |
|
| 2010 |
Ahmed MR, Berthet A, Bychkov E, Porras G, Li Q, Bioulac BH, Carl YT, Bloch B, Kook S, Aubert I, Dovero S, Doudnikoff E, Gurevich VV, Gurevich EV, Bezard E. Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease. Science Translational Medicine. 2: 28ra28. PMID 20410529 DOI: 10.1126/Scitranslmed.3000664 |
0.729 |
|
| 2009 |
Nadjar A, Berton O, Guo S, Leneuve P, Dovero S, Diguet E, Tison F, Zhao B, Holzenberger M, Bezard E. IGF-1 signaling reduces neuro-inflammatory response and sensitivity of neurons to MPTP. Neurobiology of Aging. 30: 2021-30. PMID 18394756 DOI: 10.1016/j.neurobiolaging.2008.02.009 |
0.554 |
|
| 2007 |
Aubert I, Guigoni C, Li Q, Dovero S, Bioulac BH, Gross CE, Crossman AR, Bloch B, Bezard E. Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenylalanine-induced dyskinesia. Biological Psychiatry. 61: 836-44. PMID 16950226 DOI: 10.1016/J.Biopsych.2006.06.038 |
0.751 |
|
| 2005 |
Guigoni C, Dovero S, Aubert I, Li Q, Bioulac BH, Bloch B, Gurevich EV, Gross CE, Bezard E. Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning. The European Journal of Neuroscience. 22: 283-7. PMID 16029219 DOI: 10.1111/J.1460-9568.2005.04196.X |
0.739 |
|
| 2005 |
Guigoni C, Li Q, Aubert I, Dovero S, Bioulac BH, Bloch B, Crossman AR, Gross CE, Bezard E. Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 2102-7. PMID 15728850 DOI: 10.1523/Jneurosci.5059-04.2005 |
0.764 |
|
| 2005 |
Aubert I, Guigoni C, HÃ¥kansson K, Li Q, Dovero S, Barthe N, Bioulac BH, Gross CE, Fisone G, Bloch B, Bezard E. Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Annals of Neurology. 57: 17-26. PMID 15514976 DOI: 10.1002/Ana.20296 |
0.728 |
|
| 2004 |
Pioli EY, Dovero S, Bioulac BH, Gross CE, Bezard E. Asymmetrically lesioned mesencephalon in healthy rodents: call for caution. Brain Research. 1022: 251-3. PMID 15353237 DOI: 10.1016/j.brainres.2004.07.014 |
0.758 |
|
| 2003 |
Bezard E, Dovero S, Belin D, Duconger S, Jackson-Lewis V, Przedborski S, Piazza PV, Gross CE, Jaber M. Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 10999-1007. PMID 14657156 DOI: 10.1523/Jneurosci.23-35-10999.2003 |
0.697 |
|
| 2003 |
Meissner W, Dovero S, Bioulac B, Gross CE, Bezard E. Compensatory regulation of striatal neuropeptide gene expression occurs before changes in metabolic activity of basal ganglia nuclei. Neurobiology of Disease. 13: 46-54. PMID 12758066 DOI: 10.1016/S0969-9961(03)00011-1 |
0.742 |
|
| 2003 |
Gross CE, Ravenscroft P, Dovero S, Jaber M, Bioulac B, Bezard E. Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice. Journal of Neurochemistry. 84: 1246-55. PMID 12614325 DOI: 10.1046/j.1471-4159.2003.01600.x |
0.751 |
|
| 2001 |
Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guilloteau D, Crossman AR, Bioulac B, Brotchie JM, Gross CE. Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 6853-61. PMID 11517273 DOI: 10.1523/Jneurosci.21-17-06853.2001 |
0.803 |
|
| 2001 |
Baufreton J, Garret M, Dovero S, Dufy B, Bioulac B, Taupignon A. Activation of GABA(A) receptors in subthalamic neurons in vitro: properties of native receptors and inhibition mechanisms. Journal of Neurophysiology. 86: 75-85. PMID 11431489 DOI: 10.1152/JN.2001.86.1.75 |
0.556 |
|
| 2001 |
Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guilloteau D, Crossman AR, Bioulac B, Brotchie JM, Gross CE. Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease The Journal of Neuroscience. 21: 6853-6861. DOI: 10.1523/JNEUROSCI.21-17-06853.2001 |
0.735 |
|
| 2000 |
Bezard E, Dovero S, Imbert C, Boraud T, Gross CE. Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice. Synapse (New York, N.Y.). 38: 363-8. PMID 11020240 DOI: 10.1002/1098-2396(20001201)38:3<363::Aid-Syn16>3.0.Co;2-A |
0.667 |
|
| 1999 |
Guehl D, Bezard E, Dovero S, Boraud T, Bioulac B, Gross C. Trichloroethylene and parkinsonism: a human and experimental observation. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 6: 609-11. PMID 10457397 DOI: 10.1046/J.1468-1331.1999.650609.X |
0.766 |
|
| 1999 |
Bezard E, Gross CE, Fournier MC, Dovero S, Bloch B, Jaber M. Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter. Experimental Neurology. 155: 268-73. PMID 10072302 DOI: 10.1006/exnr.1998.6995 |
0.718 |
|
| 1998 |
Bezard E, Boraud T, Imbert C, Dovero S, Bioulac B, Gross CE. Towards a dynamic approach of experimental parkinsonism Progress in Neuro-Psychopharmacology and Biological Psychiatry. 22: 1317-1329. DOI: 10.1016/S0278-5846(98)00072-4 |
0.676 |
|
| 1997 |
Bezard E, Dovero S, Bioulac B, Gross C. Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice. Experimental Neurology. 148: 288-92. PMID 9398471 DOI: 10.1006/exnr.1997.6648 |
0.768 |
|
| 1997 |
Bezard E, Dovero S, Bioulac B, Gross CE. Kinetics of nigral degeneration in a chronic model of MPTP-treated mice. Neuroscience Letters. 234: 47-50. PMID 9347943 DOI: 10.1016/S0304-3940(97)00663-0 |
0.776 |
|
| Show low-probability matches. |